Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

202.93
+0.29000.14%
Post-market: 203.020.0900+0.04%19:37 EDT
Volume:2.29M
Turnover:465.17M
Market Cap:10.28B
PE:32.15
High:205.31
Open:203.94
Low:202.75
Close:202.64
52wk High:217.12
52wk Low:138.79
Shares:50.65M
Float Shares:50.65M
Volume Ratio:1.60
T/O Rate:4.51%
Dividend:0.41
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.26
PE(LYR):-135.83

Loading ...

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Yesterday

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

TIPRANKS
·
Yesterday

Scholar Rock announces FDA approval of isembyld

TIPRANKS
·
Yesterday

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Yesterday

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Pharming wins FDA nod to extend Joenja use to younger APDS children

TIPRANKS
·
Yesterday

Exchange-Traded Funds, US Equities Rise After Midday

MT Newswires Live
·
Yesterday

Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside

TIPRANKS
·
Yesterday

Political and General News Events from September 11

Reuters
·
Sep 11

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

Stock News
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day

TIPRANKS
·
Sep 11

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

TIPRANKS
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Sector Update: Healthcare

MT Newswires Live
·
Sep 11

Biohaven clinical hold adds level of uncertainty, says H.C. Wainwright

TIPRANKS
·
Sep 11

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10